Rashmi R Shah

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 7

Top Topics

Oral Anticoagulants

Coronavirus Disease

Top Venues

Journal of clinical pharmacy and therapeutics

Drug safety - case reports

British journal of pharmacology

Therapeutic advances in drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Rashmi R Shah
Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing. Journal of clinical pharmacy and therapeutics 46 (1) (2020)
Rashmi R Shah
Genotype-guided warfarin therapy: Still of only questionable value two decades on. Journal of clinical pharmacy and therapeutics 45 (3) (2020)
Rashmi R Shah, Peter D Stonier
Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty. Therapeutic advances in drug safety 9 (8) (2018)
Rashmi R Shah, Peter D Stonier
Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead. Journal of clinical pharmacy and therapeutics 44 (1) (2018)
Rashmi R Shah
Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity? Journal of clinical pharmacy and therapeutics 44 (1) (2018)
Rashmi R Shah
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics. Drug safety - case reports 4 (1) (2017)
Xavier Ligneau, Rashmi R Shah, Isabelle Berrebi-Bertrand, Gary R Mirams, Philippe Robert, Laurent Landais, Pierre Maison-Blanche, Jean-François Faivre, Jeanne-Marie Lecomte, Jean-Charles Schwartz
Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro-arrhythmia Assay initiative studies. British journal of pharmacology 174 (23) (2017)